stanley erck  novavax  inc  zoominfocom stanley c erck  jamaica plain ma  intelius sign in we found stanley c erck in jamaica plain ma stanley c erck intelius found that stanley c erck is a male between  and  years old from jamaica plain ma we have connected them to  addresses  phones and  relatives or associates get report now age stanley c erck is in his s stanley has lived in jamaica plain ma washington dc watertown ma stanleys relatives ted erck matthew erck dara erck elizabeth erck stanley c erck zodiac signaries gendermale professional status president and chief executive officer at novavax  inc get report now want to know more about stanley get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about stanley or use our people search engine to find others get background check on stanley c erck get a criminal check on stanley c erck get a public record report on stanley c erck get a people search report on stanley c erck stanley c ercks contact information known cities lived in find out where stanley c erck has lived as well as stanley c ercks phone numbers and email addresses stanley c erck has lived in  states massachusetts address for stanley c erck  r s jamaica plain ma has lived in jamaica plain ma washington dc get full address report phone numbers associated with stanley c erck    jamaica plain ma    jamaica plain ma    aspen co get full phone report email addresses associated with stanley c erck skcom skcom scom get email report stanley c ercks education information known schools attended learn about stanley c ercks academic history find out which schools stanley c erck attended the dates attended as well as the degrees stanley c erck received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act stanley c erck has attended  schools university of chicago university of illinois at urbanachampaign the university of chicago  booth school of business  –  stanley c erck has a mba in economics finance stanley c ercks professional information information regarding stanley c ercks professional history find out previous places stanley c erck has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act stanley c erck has worked at  places company novavax  inc title president and chief executive officer company pht corporation title chief executive officer stanley c ercks experience title president and chief executive officer company novavax  inc job details company size  mil to less than  mil  employee range  to less than  novavax inc is a clinical stage vaccine company committed to leading the global fight against infectious diseases by creating novel highly potent vaccines that are safer and more effective than current preventive options title chief executive officer company pht corporation job details company size  mil to less than  mil  employee range  to less than  advanced information technology solutions for the pharmaceutical industry pioneer in revolutionizing electronic web data capture and control systems for managing clinical trials pht corp provides pharmaceutical companies cros biotechnology firms and medical device companies with a technologybased infrastructure for the collection and processing of the data used in the development and marketing of pharmaceutical compounds additional professional information on stanley c erck see stanley c ercks linkedin profile stanley c ercks social network and potential email matches find out potential social network profiles and potential email usernamed for stanley c erck stanley c ercks known social networks and potential email matches find all of stanley c ercks social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches stanley erck username matches stanleyerck erckstanley stanleyerck erckstanley stanleyerck erckstanley stanleyerck erckstanley serck popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches s erck intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here novavax inc announces stanley erck appointed president ceo employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       novavax inc nvax announces stanley erck appointed president  ceo tweet   am rockville md april   prnewswire  novavax inc nasdaqnvax  news announced today that stanley c erck its former executive chairman has been appointed to the position of president and chief executive officer and will remain as a member of the board of directors in addition current board member james young phd will assume the position of chairman of the board mr erck has been an active member of novavaxs senior management team for the last year and has had extensive experience in the biotechnology sector and has successfully brought infectious disease product candidates into latestage clinical trials he also has had significant experience in managing a large advanced development contract with the department of health and human services from  mr erck served as president and chief executive officer of iomai corporation leading the company through an initial public offering and a merger with intercell an austrian vaccine company prior to iomai he served as president and chief executive officer of procept a publiclytraded immunology company as vice presidentcorporate development at integrated genetics now genzyme and in management positions within baxter international mr erck received his undergraduate degree from the university of illinois and his masters in business administration from the university of chicago graduate school of business mr erck sits on the board of directors of biocryst pharmaceuticals maxcyte and mdbio foundation dr young who became a board member in april  has over  years of experience in the fields of molecular genetics microbiology immunology and pharmaceutical development he was previously president of research and development including responsibility for regulatory affairs at medimmune where he was instrumental in the development of flumist® and synagis® in  dr young was awarded the albert b sabin humanitarian award prior to medimmune dr young was influential in building the department of molecular genetics at smith kline  french laboratories now part of glaxosmithkline and culminated as director department of molecular genetics as the company continues its transition into a commercial operation we are pleased to have attracted high caliber professionals such as stan and jim to now take the leadership roles at novavax commented gary evans of novavaxs board of directors we expect these gentlemen will dynamically lead the company and its vaccine candidates towards important worldwide products their strong leadership skills and broad experience in drug development will be invaluable to novavax as the company works to advance its infectious disease pipeline of viruslike particle vlp vaccine candidates i am a strong believer in the potential of recombinantbased vlp vaccine technology and was delighted to join novavaxs board of directors in june  commented mr erck today i am honored to assume my new role and to lead novavax in its next phase of growth including the clinical regulatory and business development activities that will be required to bring our vaccine candidates to potential commercialization i also look forward to working and collaborating with the superb team of employees at novavax as we strive to bring new medical advances with vaccines for subjects with unmet medical needs mr evans concluded we would like to especially thank dr rahul singhvi for his past leadership during important and challenging phases of novavaxs growth and development rahul has served novavax as its president  ceo for the past  years and during that time he has been instrumental in positioning the company for success with our vlp vaccine candidates we all wish him nothing but the best in his future endeavors and will be anxiously watching for his next achievements about novavax novavax inc nasdaqnvax  news a clinicalstage biopharmaceutical company employs its cuttingedge technology to create nextgeneration vaccines to prevent serious infectious diseases such as pandemic and seasonal influenza and respiratory syncytial virus rsv the companys proprietary vlp technology and singleuse bioprocessing system enables rapid vaccine development and production where and when its needed worldwide the company has formed a joint venture with cadila pharmaceuticals named cpl biologicals to develop and manufacture vaccines biological therapeutics and diagnostics in india additional information about novavax is available on the companys website wwwnovavaxcom forward looking statements statements herein relating to the future of novavax and its ongoing development of its vlp vaccine products are forwardlooking statements novavax cautions that these forwardlooking statements are subject to numerous risks and uncertainties which could cause actual results to differ materially from those expressed or implied by such statements these risks and uncertainties include those identified under the heading risk factors in the novavax annual report on form k for the year ended december   and filed with the securities and exchange commission we caution investors not to place considerable reliance on the forwardlooking statements contained in this press release you are encouraged to read our filings with the sec available at wwwsecgov for a discussion of these and other risks and uncertainties the forwardlooking statements in this press release speak only as of the date of this document and we undertake no obligation to update or revise any of the statements our business is subject to substantial risks and uncertainties including those referenced above investors potential investors and others should give careful consideration to these risks and uncertainties read at biospacecom related news novavax inc nvax awarded hhsbiomedical advanced research and development authority barda contract valued at up to  million to develop pandemic and seasonal influenza vaccines for us government using recombinant vlp technology noel doheny appointed as new ceo of epigenomics inc novavax inc nvaxs vlp influenza vaccine named one of top  drugs in development today amicus therapeutics inc fold announces transition of ceo novavax inc nvax presents final results from hn influenza vaccine phase  trial at world health organization meeting immunovaccine inc announces resignation of president and chief executive officer novavax inc nvax licenses recombinant vlp influenza vaccine to lg life sciences ltd for south korea and other countries depomed inc depo ceo pelzel resigns for personal reasons novavax inc nvax licenses recombinant vlp influenza vaccine to lg life sciences ltd for south korea and other countries roche rhhby vet takes ceo job at boston’s enlight biosciences please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • novavax inc   • biotechpharma  personnel                 stanley c erck  imapac media home what we do business conferences  trade fairs executive trainings market intelligence who we are our philosophy mission vision  character our people how we give why education our collective impact our heart join us why work for imapac who we need current openings contact contact stanley c erck mrerck was named president and chief executive officer of novavax in april  he became a novavax director in june  and beginning in february  served as its executive chairman of the board from  to  mr erck was president and chief executive officer of iomai corporation leading the company through an initial public offering and a merger with intercell an austrian vaccine company and through the development of a latestage infectious disease product candidate prior to iomai mr erck served as president and chief executive officer of procept a publicly traded immunology company as vice president corporate development at integrated genetics now genzyme and in management positions within baxter international mr erck currently sits on the board of directors of biocryst pharmaceuticals maxcyte inc and the mdbio foundation he received his undergraduate degree from the university of illinois and his masters in business administration from the university of chicago graduate school of business upcoming events   th bioplasma world asia  –  september  shanghai china where asia’s plasma and blood products industry convene annually running consecutively for  years bioplasma world asia has firmly established itself as the most definitive and most important annual meeting place for the plasma products industry continuing the tradition and success of the past this year too the event will bring you fresh perspectives from asian and global experts on the industry’s most pressing topics  read more  cell therapy world asia    –  september  seoul south korea cell therapy world asia  is bringing together asia’s best of best in cell therapy development and manufacturing this will be the most targeted conference that will attract cell therapy companies in asia to discuss and debate on best practices and innovations in this space  read more   th annual retirement living  senior care southeast asia     october  kuala lumpur  malaysia retirement living  senior care southeast asia  is tailored to bring together developers operators investors and service providers in the aged care sector to shape the way we view southeast asia’s high and middle senior housing market  read more   th annual retirement living world india    –  december  bengaluru india th annual retirement living world india will be attended by retirement village developers financiers operators and aged care professionals from india and the rest of the world it’s your onestop solution to reach out to the region’s retirement living industry  read more  nvax stanley c erck insider trades for novavax inc x tweet share this bulletin get news bulletins by email bulletin teavana shutdown by starbucks called latest mall casualty » investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close novavax inc nasdaq nvax go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus novavax inc market open  real time quotes jul    pm nvax quoteszigmancomposite   change   volume volume m real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual stanley c erck mr stanley c erck is president chief executive officer  director at novavax inc and independent director at biocryst pharmaceuticals inc he is on the board of directors at novavax inc biocryst pharmaceuticals inc maxcyte inc and mdbio foundation mr erck was previously employed as president  chief executive officer by iomai corp headglobal regulatory affairs vaccines by baxter international inc president  chief executive officer by procept inc and vice presidentcorporate development by integrated genetics inc he received his undergraduate degree from the university of illinois and an mba from the university of chicago booth school of business transactions date shares transaction value     acquisition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr stanley c erck president chief executive officer  director mr barclay a phillips chief financial officer treasurer  senior vp dr james f cummings vpclinical development  translational medicine dr gregory m glenn presidentresearch  development ms jill hoyt vice presidenthuman resources  administration mr iksung cho vice presidentbiostatistics ms jody lichaa vice presidentquality assurance dr jeffrey stoddard vice presidentmedical affairs mr brian rosen vice presidentgovernment affairs  policy dr cynthia n oliver senior vpprocess development operations mr denise giangola courbron vice presidentglobal program management mr john j trizzino senior vice presidentcommercial operations mr mervyn l hamer vice presidentmanufacturing mr russell p wilson senior vice presidentbusiness development dr timothy jon hahn senior vpglobal manufacturing operations dr louis f fries chief medical officer  senior vice president dr rajiv indravadan modi director ms gail koziara boudreaux director mr john o marsh directoremeritus dr andrea n flynn senior managerinvestor relations mr john a herrmann secretary senior vice president  general counsel ms amy b fix senior vice presidentregulatory affairs dr james f young chairman dr richard h douglas independent director mr gary c evans independent director mr michael a mcmanus independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest phow venezuela chaos could spark oil rally opec has failed to achieve pwhy mccain shot down obamacare repeal pchip stocks are cool again but reality is here pintel earnings have message for amd and nvidia ‘bring it on’ pamazon’s freespending ways hit earnings but don’t expect a shift to thrift pstarbucks’ teavana stores are the latest casualty at the mall pwagerebound story takes another hit after drab eci report pwhat is an ico ptrump’s sketch of new york city skyline auctioned off pwells fargo fda plan to lower nicotine could be opportunity for altria philip morris phealthcare fund managers say a spike in drugs and devices will produce big returns pthese companies spent over  billion buying back shares while their ceos were dumping them pstock market edges lower on track for weekly losses awells fargo will pay  million to overcharged auto loan consumers agold aims for thirdweekly gain as dollar holds loss after gdp report acharting a bulltrend whipsaw nasdaq’s key reversal fuels sector rotation again aa global investment strategist offers up a summer reading list to make you a better investor athis fund strategist says there’s at least one way companies can survive amazon’s onslaught awells fargo fda plan to lower nicotine could be opportunity for altria philip morris ahere’s one trump fan who might make you some money loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft stanley c erck  president  chief executive officer at novavax inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink stanley c erck president  chief executive officer at novavax inc overview in the news relationships paths education career history boards  committees political donations public holdings transactions stanley c erck president  chief executive officer at novavax inc overview age  born  notable companies novavax inc intercell usa inc procept inc board seats  number of relationships this person is connected to  people in the news see more thomson reuters one july   novavax announces positive topline data from phase  older adult trial and provides path forward for rsv f vaccine programs thomson reuters one may   novavax announces the promotion of dr james f cummings to vice president clinical development and translational medicine globenewswire may   novavax reports first quarter  financial results thomson reuters one may   novavax reports first quarter  financial results globenewswire may   novavax reports first quarter  financial results see full news coverage and complete stories with relsci professional create your news feed see more relationships see details richard douglas former senior vice presidentcorporate development at sanofi genzyme james f young chairman chief executive  financial officer at targeted microwave solutions inc jane e hager founder at novavax inc michael a mcmanus jr former president  chief executive officer at misonix inc gary c evans chairman  chief executive officer at energy hunter resources inc rajiv indravadan modi chairman  managing director at cadila pharmaceuticals ltd douglas a doerfler executive director president  chief executive officer at maxcyte inc jon p stonehouse former president  chief executive officer at biocryst pharmaceuticals inc gail k boudreaux chief executive officer at gkb global health llc john holaday partner at montgomery pacific group llc see  more listings with relsci professional start my free trial ➤ see  more paths to stanley c erck stanley c erck you connections via relationship science stanley c erck sync your contacts to see how you can connect with stanley c erck start my free trial ➤ see more educational background undergraduate degree  university of illinois at urbana  champaign the university of illinois at urbana–champaign is a public researchintensive university in the us state of illinois it is the flagship campus of the university of illinois system the university of illinois at urbana–champaign is the second oldest public university in the state after illinois state university and is a founding member of the big ten conference it is considered a public ivy and is a member of the association of american universities mba  university of chicago  booth school of business the university of chicago booth school of business is a graduate business school located in chicago illinois at the university of chicago formerly known as the university of chicago graduate school of business chicago booth is the secondoldest business school in the us the first such school to offer an executive mba program and the first to initiate a phd program in business the school was renamed in  following a  million endowment gift to the school by alumnus david g booth the school has the thirdlargest endowment of any business school the schools flagship campus is located in the hyde park neighborhood of chicago on the main campus of the university the school also maintains additional campuses in london and asia originally singapore but in july  a move to hong kong was announced as well as in downtown chicago on the magnificent mile in addition to conducting graduate business programs the school conducts research in the fields of finance economics quantitative marketing research and accounting chicago booth is currently ranked first in the united states by bloomberg businessweek and first globally by the economist career history president  chief executive officer   current novavax inc novavax inc operates as a clinicalstage biopharmaceutical company which engages in the provision of development of recombinant nanoparticle vaccines and adjuvants its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus seasonal influenza pandemic influenza and ebola virus the company was founded in  and is headquartered in gaithersburg md president  chief executive officer   prior intercell usa inc intercell usa inc discovers and develops vaccines and immune system stimulants the vaccine patch enhances the efficacy of existing vaccines enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market the company was founded by gregory m glenn and dean p lewis in september  and is headquartered in gaithersburg md president  chief executive officer prior procept inc procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and lifethreatening immune system disorders procept is developing therapeutics for the treatment of autoimmune disease organ transplant rejection and infectious diseases such as aids and tuberculosis the company is located in san diego ca headglobal regulatory affairs vaccines prior baxter international inc baxter international inc nysebax through its subsidiaries develops manufactures and markets products that save and sustain the lives of people with hemophilia immune disorders infectious diseases kidney disease trauma and other chronic and acute medical conditions as a global diversified healthcare company baxter applies a unique combination of expertise in medical devices pharmaceuticals and biotechnology to create products that advance patient care worldwide baxter had  sales of  billion and has approximately  employees vice presidentcorporate development prior integrated genetics inc boards  committees corporate boards ▾ nonexecutive director   current maxcyte inc maxcyte inc is a biotechnology and pharmaceuticals company it develops and supplies cell engineering products and technologies to biopharmaceutical firms engaged in cell therapy drug discovery and development biomanufacturing gene editing and immunooncology markets its products include maxcyte stx maxcyte vlx maxcyte gt transfection insourcing services processing assemblies and quality systems the company was founded by douglas a doerfler shawn j green and vininder singh in june  and is headquartered in gaithersburg md director   current novavax inc novavax inc operates as a clinicalstage biopharmaceutical company which engages in the provision of development of recombinant nanoparticle vaccines and adjuvants its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus seasonal influenza pandemic influenza and ebola virus the company was founded in  and is headquartered in gaithersburg md member board of directors   current biocryst pharmaceuticals inc founded in  biocryst has approximately  employees between the company’s headquarters in durham north carolina and its discovery center of excellence in birmingham alabama with expertise in drug discovery clinical development and regulatory affairs we continue to advance our clinical programs and to generate new compounds from our own discovery engine we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives the commitment of biocryst has remained unchanged we continue to be passionate about advancing novel therapeutics for patients with serious diseases member board of directors   current intercell usa inc intercell usa inc discovers and develops vaccines and immune system stimulants the vaccine patch enhances the efficacy of existing vaccines enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market the company was founded by gregory m glenn and dean p lewis in september  and is headquartered in gaithersburg md nonprofit boards ▾ executive director current mdbio foundation political donations   kirsten elizabeth rutnik gillibrand senator from new york   christopher van hollen jr senator at office of the senator from maryland christopher van hollen   barbara ann mikulski former senator from maryland   alfonse m damato former senator from new york public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden novavax inc purchases novavax ab other affiliations stanley c erck is affiliated with novavax inc intercell usa inc procept inc baxter international inc integrated genetics inc maxcyte inc novavax inc biocryst pharmaceuticals inc intercell usa inc mdbio foundation youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ erck stanley c  the wall street transcript stanley c erck stanley c erck is president and chief executive officer and director of iomai corporation mr erck applies his  years of management experience in the healthcare and biotechnology industry baxter international procept and integrated genetics to shepherd the development and commercialization of iomai technology in addition to successfully negotiating major alliances with pharmaceutical and biotechnology companies and bringing products into clinical trials as ceo he has managed the process of developing companies from private funding through an ipo raising over  million mr erck received his bs from the university of illinois and an mba from the university of chicago related interviewsstanley erck  iomai corporationmay  stanley erck  iomai corporationmay   cartlatest newsall american usc footbal player joseph m boskovich jr now picks all american value stocks for his clientspaul hogan picks tech dividend growers microchip technology nasdaqmchp xilinx nasdaqxlnx and versum materials nysevsm gallons of water to produce a mcdonalds nysemcd quarter pounder how will investors profitthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsbuilding diversified portfolios with quality global equitiesgregory d padillaalberto jimenez crespo published july   in investing strategiescompanies covered amzn  aapl mu whr kimbera gs vod ppg shw viv pey buy building accountability and avoiding mistakes through the decision processdean pagonis published july   in investing strategiescompanies covered cmp sbh amzn ulta cvs lrlcy kmb www sdf buy finding optimal balance sheets by utilizing high yield market expertisezach miller published july   in investing strategiescompanies covered lsxmk siri bll chtr armk buy most popular reportsinvesting strategies published july  buy wireless communications  telecom published july  buy investing strategies published july  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsbuilding diversified portfolios with quality global equitiesbuilding accountability and avoiding mistakes through the decision processfinding optimal balance sheets by utilizing high yield market expertise analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google stanley c erck president and ceo director novavax timesjavascript is disabled market profiles login sign up login sign up   edit person stanley c erck president and ceo director at novavax location greater boston area ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop stanley c erck president and ceo director at novavax location greater boston area ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop stanley c erck was elected a director in december  mrerck was named president and chief executive officer of novavax in april  from  mr erck served as president and chief executive officer of iomai corporation leading the company through an initial public offering and a merger with intercell an austrian vaccine company and through the development of a latestage infectious disease product candidates prior to iomai mr erck served as president and chief executive officer of procept a publicly traded immunology company as vice president corporate development at integrated genetics now genzyme and in management positions within baxter international mr erck currently sits on the board of directors of novavax maxcyte and the mdbio foundation a private charitable organization he received his undergraduate degree from the university of illinois and his masters in business administration from the university of chicago graduate school of business  companies in career na related markets  colleagues na related investments alias na industry pharmaceuticals tags infectious disease autoimmune disease genetic disease immunology topics of influence na na careers achievements investments related people edit view all stanley c erckcareer   novavax president and ceo director  biocryst pharmaceuticals board member  maxcyte inc board member  to  iomai now intercell usa ceo  to  pht corporation ceo  to  procept ceo competencies edit view all stanley c erckeducation  the university of chicago  booth school of business economics finance edit stanley c erckachievements and recognitions add milestone no milestones has been recorded for stanley c erck edit stanley c ercklinks add link no links has been recorded for stanley c erck stanley c erckinvestmentsacquisitions no investments has been recorded for stanley c erck stanley c erckinvestments representing others no investment reps has been recorded for stanley c erck stanley c erckrelated people colleagues at novavax jody lichaa vice president quality assurance oct chris dunne vice president finance jun brian rosen vice president government affairs  public policy feb view all peers  joseph m hogan president and ceo of align technology waleed hassanein president  ceo of transmedics laura brege president  chief executive officer of nodality peter maag president and ceo of caredx niamh pellegrini president  ceo of autonomic technologies jon p stonehouse president chief executive officer of biocryst pharmaceuticals view all stanley c erckrecommended market profiles life sciences kleiner perkins caufield  byers  or more employees  companies